The FDA has declined to approve Orexo AB's high-dose prescription drug for opioid overdose, the company announced on Tuesday.
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Advertisement
Recommendations
Advertisement